🇺🇸 FDA
Patent

US 8895521

Methods and compositions for the treatment of uveitis

granted A61KA61K31/7088A61K45/06

Quick answer

US patent 8895521 (Methods and compositions for the treatment of uveitis) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/7088, A61K45/06, A61P, A61P27/02